Patient BenefitsEffective Chemotherapy Agent For Blood Cancers
Product Description
Indicated For: AML, ALL, CML, and other leukemias
Active Ingredient: Cytarabine 1000mg
Mechanism of Action: Inhibits DNA synthesis, preventing cancer cell growth
Dosage Form: Intravenous injection (1 vial per pack)
Manufactured By: Pfizer Ltd (WHO-GMP certified)
Patient Benefits: Effective chemotherapy agent for blood cancers
Medical Supervision Required: Administered by healthcare professionals
Cytosar 1000mg Injection contains Cytarabine (1000mg), a chemotherapy drug used in the treatment of leukemia, including acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), and chronic myeloid leukemia (CML). It works by interfering with the growth of cancer cells, slowing or stopping their spread in the body. Manufactured by Pfizer Ltd, Cytosar 1000mg is administered via intravenous (IV) injection under medical supervision. It is a crucial part of chemotherapy regimens and is often combined with other anti-cancer medications. Patients should be monitored for side effects, and dosage should be tailored based on medical advice.
Interested in this product? Ask for more details & Latest Price from seller